|
|
|
Volumn 22, Issue 4, 2003, Pages 60-75
|
|
How can valid informed consent be obtained from a psychotic patient for research into psychosis? Three perspectives.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLACEBO;
PSYCHOTROPIC AGENT;
ARTICLE;
AUSTRALIA;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
COGNITION;
ETHICS;
HUMAN;
HUMAN EXPERIMENT;
INFORMED CONSENT;
INTERPERSONAL COMMUNICATION;
LEGAL ASPECT;
LIVING WILL;
MENTAL CAPACITY;
MENTAL HEALTH THERAPIES;
MENTAL PATIENT;
METHODOLOGY;
PSYCHOLOGICAL ASPECT;
PSYCHOSIS;
RESEARCH ETHICS;
RESEARCH SUBJECT;
SCHIZOPHRENIA;
STANDARD;
TREATMENT WITHDRAWAL;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
MENTAL HEALTH THERAPIES;
ADVANCE DIRECTIVES;
AUSTRALIA;
COGNITION;
DISCLOSURE;
ETHICS, RESEARCH;
HUMAN EXPERIMENTATION;
HUMANS;
INFORMED CONSENT;
MENTAL COMPETENCY;
MENTALLY ILL PERSONS;
PLACEBOS;
PSYCHOTIC DISORDERS;
PSYCHOTROPIC DRUGS;
RESEARCH DESIGN;
RESEARCH SUBJECTS;
SCHIZOPHRENIA;
WITHHOLDING TREATMENT;
|
|
EID: 2442574934
PISSN: 13212753
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
